Long-Term Effects of COVID-19 on Chronic Obstructive Pulmonary Disease

被引:0
作者
Lee, Chi-Tai [1 ]
Wang, Ping-Huai [1 ,2 ,3 ]
Cheng, Shih-Lung [1 ,4 ]
机构
[1] Far Eastern Mem Hosp, Dept Internal Med, Div Pulmonol, 21 Sec 2 Nan-Ya South Rd, New Taipei City 220, Taiwan
[2] Asia Eastern Univ Sci & Technol, Dept Nursing, New Taipei City, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei City, Taiwan
[4] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Tayuan, Taiwan
关键词
Coronavirus disease; COVID-19; SARS-CoV-2; COPD; outcome;
D O I
10.2147/COPD.S523149
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Research has demonstrated that chronic obstructive pulmonary disease (COPD) is a negative prognostic factor for patients with the coronavirus disease 2019 (COVID-19). The long-term complications of COVID-19 among patients with COPD remain poorly understood due to limited studies. Methods: This retrospective study included patients with COPD who underwent regular follow-ups in a medical center between January 1, 2020, and December 31, 2022. The patients were categorized into COVID-19 and non-COVID-19 groups. Comparative analyses were conducted to assess clinical demographics, characteristics, acute exacerbations of COPD (AECOPD), and survival rates between the two groups. Subgroup analysis was performed based on inpatient and outpatient status within the COVID-19 group. Results: Of the 696 patients with COPD, 86 (12.4%) were included in the COVID-19 group, while 610 (87.6%) were included in the non-COVID-19 group. Patients in the COVID-19 group were significantly older (age: 75.0 +/- 8.8 years versus 72.0 +/- 9.0 years, p = 0.004), exhibited higher mortality rates (4.6% versus 0%, p < 0.001), and increased annual times of AECOPD (0.17 versus 0.08, p = 0.018) than those in the non-COVID-19 group after COVID-19. Multivariate analysis revealed that COVID-19 infection is an independent risk factor for increased AECOPD incidence (adjusted odds ratio: 1.74; 95% confidence interval [CI]: 1.07- 2.83, p = 0.024). Within the COVID-19 group, the inpatient subgroup exhibited a higher prevalence of heart failure comorbidity (20% versus 2.8%, p = 0.035) and lower forced vital capacity than the outpatient subgroup (2.03 +/- 0.60 L versus 2.56 +/- 0.72 L, p = 0.016). Conclusion: Age is a significant risk factor for COVID-19 infection among patients with COPD. After COVID-19, these patients exhibit an increased frequency of severe exacerbations and a high risk of mortality. Notably, the susceptibility to severe exacerbations persists regardless of whether the patients receive inpatient or outpatient care.
引用
收藏
页码:2539 / 2548
页数:10
相关论文
共 36 条
[1]  
[Anonymous], COVID-19 Dashboard
[2]  
[Anonymous], 2025, Global Strategy for Asthma Management and Prevention
[3]  
[Anonymous], Daily New Confirmed Cases Between Canada and China, Our World in Data
[4]   Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study [J].
Aveyard, Paul ;
Gao, Min ;
Lindson, Nicola ;
Hartmann-Boyce, Jamie ;
Watkinson, Peter ;
Young, Duncan ;
Coupland, Carol A. C. ;
San Tan, Pui ;
Clift, Ashley K. ;
Harrison, David ;
Gould, Doug W. ;
Pavord, Ian ;
Hippisley-Cox, Julia .
LANCET RESPIRATORY MEDICINE, 2021, 9 (08) :909-923
[5]   The Complex Association between COPD and COVID-19 [J].
Awatade, Nikhil T. ;
Wark, Peter A. B. ;
Chan, Andrew S. L. ;
Al Mamun, S. M. Abdullah ;
Esa, Nurul Yaqeen Mohd ;
Matsunaga, Kazuto ;
Rhee, Chin Kook M. ;
Hansbro, Philip M. ;
Sohal, Sukhwinder Singh .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
[6]   Inflammatory mechanisms in patients with chronic obstructive pulmonary disease [J].
Barnes, Peter J. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (01) :16-27
[7]   Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis [J].
Bellou, Vanesa ;
Tzoulaki, Ioanna ;
van Smeden, Maarten ;
Moons, Karel G. M. ;
Evangelou, Evangelos ;
Belbasis, Lazaros .
EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (02)
[8]   Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With Coronavirus Disease 2019 (COVID-19) [J].
Bhimraj, Adarsh ;
Morgan, Rebecca L. ;
Shumaker, Amy Hirsch ;
Baden, Lindsey ;
Cheng, Vincent Chi Chung ;
Edwards, Kathryn M. ;
Gallagher, Jason C. ;
Gandhi, Rajesh T. ;
Muller, William J. ;
Nakamura, Mari M. ;
O'Horo, John C. ;
Shafer, Robert W. ;
Shoham, Shmuel ;
Murad, M. Hassan ;
Mustafa, Reem A. ;
Sultan, Shahnaz ;
Falck-Ytter, Yngve .
CLINICAL INFECTIOUS DISEASES, 2022, 78 (07) :e250-e349
[9]   Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry [J].
Brenner, Erica J. ;
Ungaro, Ryan C. ;
Gearry, Richard B. ;
Kaplan, Gilaad G. ;
Kissous-Hunt, Michele ;
Lewis, James D. ;
Ng, Siew C. ;
Rahier, Jean-Francois ;
Reinisch, Walter ;
Ruemmele, Frank M. ;
Steinwurz, Flavio ;
Underwood, Fox E. ;
Zhang, Xian ;
Colombel, Jean-Frederic ;
Kappelman, Michael D. .
GASTROENTEROLOGY, 2020, 159 (02) :481-+
[10]   Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2 [J].
Cai, Guoshuai ;
Bosse, Yohan ;
Xiao, Feifei ;
Kheradmand, Farrah ;
Amos, Christopher I. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (12) :1557-1559